Benefits of influenza vaccination for low-, intermediate-, and high- risk senior citizens

Archives of Internal Medicine

Volumn 158, Issue 16, 1998, Pages 1769-1776

  Nichol, Kristin L ^a,c   Wuorenma, J ^b   Von Sternberg, T ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HEALTHPARTNERS INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GERIATRIC CARE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; UTILIZATION REVIEW;

EID: 0032517071     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.16.1769     Document Type: Article

References (54)

1. Couch RB. Advances in influenza virus vaccine research. Ann N Y Acad Sci. 1993; 685:803-812.
2. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med. 1993;153:2105-2111.
3. Lui K, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health. 1987;77: 712-716.
4. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25-44.
5. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986; 76:761-765.
6. Collins SD, Lehmann J. Excess Deaths From Chronic Disease During Influenza Epidemics. Washington, DC: US Government Printing Office; 1953:1-21. US Public Health Service publication 213.
7. Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med. 1988; 108:616-625.
8. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 1997;46(RR-9):1-25.
9. American College of Physicians. Guide for Adult Immunization. 3rd ed. Philadelphia, Pa: American College of Physicians; 1994:90-96.
10. World Health Organization. WHO announces influenza vaccine formula for 1997/ 1998: press release WHO/14. Available at: http://www.who.ch/. Accessed February 20, 1997.
11. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged ≥65 years: United States, 1973-1993. MMWR Morb Mortal Wkly Rep. 1995;44:506-507, 513-515.
12. Centers for Disease Control and Prevention. Assessing adult vaccination status at age 50 years. MMWR Morb Mortal Wkly Rep. 1995;44:561-563.
13. Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine. 1995;13:365-369.
14. Fedson DS, Hirota Y, Shin HK, et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine. 1997;14:1506-1511.
15. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis. 1987;136:550-555.
16. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol. 1992; 136:296-307.
17. Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol. 1995;24:1240-1248.
18. Larson EB, Olsen E, Cole W, Shortell S. The relationship of health beliefs and a postcard reminder to influenza vaccination. J Fam Pract. 1979;8:1207-1211.
19. Riddiough MA, Willems JS, Sanders CF, Kemp K. Factors affecting the use of vaccines: considerations for immunization program planners. Public Health Rep. 1981;96:528-535.
20. Buffington J, LaForce FM. Achievable influenza immunization rates in the elderly. N Y State Med J. 1991;91:433-435.
21. Gillick MR, Ditzion B. Influenza vaccination: are we doing better than we think? Arch Intern Med. 1991;151:1742-1744.
22. Govaert Th ME, Thijs CTMCN, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661-1665.
23. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121:947-952.
24. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980;244:2547-2549.
25. Nichol KL. Long-term success with the national health objective for influenza vaccination: an institution-wide model. J Gen Intern Med. 1992;7:595-600.
26. Margolis KL, Nichol KL, Wuorenma J, von Sternberg TL. Exporting a successful influenza vaccination program from a teaching hospital to a community outpatient setting. J Am Geriatr Soc. 1992;40:1021-1023.
27. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784.
28. Minnesota Dept of Health. Annual summary of communicable diseases reported to the Minnesota Department of Health, 1993. Dis Control Newslett. 1994; 22:25-36.
29. Minnesota Dept of Health. Annual summary of communicable diseases reported to the Minnesota Department of Health, 1994. Dis Control Newslett. 1995; 23:32-43.
30. Minnesota Dept of Health. Annual summary of communicable diseases reported to the Minnesota Department of Health, 1995. Dis Control Newslett. 1996; 24:25-40.
31. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
32. Physicians' Current Procedural Terminology. Chicago, III: American Medical Association; 1997.
33. Centers for Disease Control and Prevention. Influenza surveillance: United States, 1989-90 and 1990-91 seasons. MMWR CDC Surveill Summ. 1992;41(SS-3):35-46.
34. Centers for Disease Control and Prevention. Influenza surveillance: United States, 1991-92. MMWR CDC Surveill Summ. 1992;41(SS-5):35-46.
35. Centers for Disease Control and Prevention. Influenza surveillance: United States, 1992-93 and 1993-94. MMWR CDC Surveill Summ. 1997;46(SS-1):1-12.
36. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide 1994-95 season, and composition of the 1995-96 influenza vaccine. MMWR Morb Mortal Wkly Rep. 1995;44:292-295.
37. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine. MMWR Morb Mortal Wkly Rep. 1996;45:326-329.
38. Honkanen PO, Keistinen T, Kivela SL. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine. 1997;15:317-320.
39. Maucher JM, Gambert SR. Cost-effective analysis of influenza vaccination in the elderly. Age. 1990;13:3-9.
40. Centers for Disease Control and Prevention. Final results: Medicare influenza vaccine demonstration - selected states, 1988-1992. MMWR Morb Mortal Wkly Rep. 1993;42:601-604.
41. Helliwell BE, Drummond MF. The costs and benefits of preventing influenza in Ontario's elderly. Can J Public Health. 1988;79:175-179.
42. Scott WG, Scott HM. Economic evaluation of vaccination against influenza in New Zealand. Pharm Econ. 1996;9:51-60.
43. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: cost-effectiveness and public policy. JAMA 1983;249:3189-3195.
44. Russell LB. Opportunity costs in modern medicine. Health Aff (Millwood). 1992; 11:162-169.
45. Fedson DS. Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin. Prev Med. 1994;23: 751-755.
46. Perrotta DM, Decher M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol. 1985;122:468-476.
47. Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993;270:1956-1961.
48. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol. 1992; 136:296-307.
49. Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol. 1995;24:1240-1248.
50. Ahmed AH, Nicholson KG, Nguyen-Van Tam JS, Pearson JC. Effectiveness of influenza vaccination in reducing hospital admissions during the epidemic of 1989-90. Epidemiol Infect. 1997;118:27-33.
51. Fleming DM, Watson JM, Nicholas S, et al. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect. 1995;115:581-589.
52. Ahmed AEH, Nicholson KG, Nguyen-Van Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet. 1995;346:591-595.
53. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
54. Iezzoni LI. Risk and outcomes. In: lezzoni LI, ed. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor, Mich: Health Administration Press; 1994:1-28.